Home / DXB.AX : ASX

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does DXB.AX make money? Does DXB.AX have pricing power? What's the Earnings Whisper? Will DXB.AX profit more as the business scales? What is DXB.AX's management track record? Is DXB.AX's current price justified?

Dimerix Limited

AUD 0.24 -$0.31 (-56.36%)

ASX · 16 Sep 2026 06:10 UTC

Previous Close

AUD 0.23

Day Range

AUD 0.23AUD 0.24

Year Range

AUD 0.16AUD 0.67

Market Cap

144.1M

AVG Volume

2.06M

Trailing/Forward PE

-4.83/-

PEG ratio

0.37

Dividend Yield

Next Earnings Date

2027-03-01

Primary Exchange

Australian Securities Exchange

Revenue (AUD)

DXB.AX Revenue (AUD) by quarter
Period	Revenue (AUD)
26 Q4	2.23M
26 Q2	2.12M
25 Q4	5.3M
25 Q2	287.45K
24 Q4	450.42K
24 Q2	133.06K
23 Q4	8.98M
23 Q2	0
22 Q4	6.46M
22 Q2	0

Net Income (AUD)

DXB.AX Net Income (AUD) by quarter
Period	Net Income (AUD)
26 Q4	-13.85M
26 Q2	-15.97M
25 Q4	-344.32K
25 Q2	-12.91M
24 Q4	-10.4M
24 Q2	-6.67M
23 Q4	-4.19M
23 Q2	-9.61M
22 Q4	-4.02M
22 Q2	-6.47M

Operating Income (AUD)

DXB.AX Operating Income (AUD) by quarter
Period	Operating Income (AUD)
26 Q4	-15.45M
26 Q2	-21.73M
25 Q4	-18.91M
25 Q2	-13.1M
24 Q4	-18.3M
24 Q2	-6.76M
23 Q4	-13.14M
23 Q2	-9.69M
22 Q4	-4.31M
22 Q2	-6.61M

EBITDA (AUD)

DXB.AX EBITDA (AUD) by quarter
Period	EBITDA (AUD)
26 Q4	-15.45M
26 Q2	-21.73M
25 Q4	-18.58M
25 Q2	-13.09M
24 Q4	-10.36M
24 Q2	-6.71M
23 Q4	-4.19M
23 Q2	-9.63M
22 Q4	-4M
22 Q2	-6.46M

Cash Flows (AUD)

DXB.AX Cash Flows (AUD) by quarter
Period	Cash Flows (AUD)
26 Q4	-21.95M
26 Q2	-29.86M
25 Q4	41.29M
25 Q2	-2.26M
24 Q4	-16.54M
24 Q2	9.52M
23 Q4	-8.82M
23 Q2	-3.91M
22 Q4	-6.7M
22 Q2	-6.75M

EPS (AUD)

DXB.AX EPS (AUD) by quarter
Period	EPS (AUD)
26 Q4	-0.02
26 Q2	-0.03
25 Q4	-0
25 Q2	-0.02
24 Q4	-0.02
24 Q2	-0.02
23 Q4	-0.01
23 Q2	-0.03
22 Q4	-0.01
22 Q2	-0.02

Expenses (AUD)

DXB.AX Expenses (AUD) by quarter
Period	Expenses (AUD)
26 Q4	17.54M
26 Q2	23.85M
25 Q4	24.22M
25 Q2	13.39M
24 Q4	18.76M
24 Q2	6.9M
23 Q4	13.14M
23 Q2	9.69M
22 Q4	4.29M
22 Q2	6.59M

Cash & Debt (AUD)

DXB.AX Cash & Debt (AUD) by quarter
Period	Cash & Debt (AUD)
26 Q4	16.15M
26 Q2	38.49M
25 Q4	68.28M
25 Q2	21.11M
24 Q4	22.14M
24 Q2	14.81M
23 Q4	7.99M
23 Q2	5.71M
22 Q4	9.63M
22 Q2	16.27M

Debt ratios

DXB.AX Debt ratios by quarter
Period	Debt ratios
26 Q4	0.23
26 Q2	0.6
25 Q4	1.4
25 Q2	0.61
24 Q4	0.71
24 Q2	0.55
23 Q4	0.08
23 Q2	0.22
22 Q4	0.47
22 Q2	0.81

Margins

DXB.AX Margins by quarter
Period	Margins
26 Q4	0%
26 Q2	0%
25 Q4	100%
25 Q2	100%
24 Q4	100%
24 Q2	100%
23 Q4	100%
22 Q4	100%
21 Q4	100%
21 Q2	86.05%

Return on Capital

DXB.AX Return on Capital by quarter
Period	Return on Capital
26 Q4	93.83%
26 Q2	949.76%
25 Q4	-2.57%
25 Q2	-180.06%
24 Q4	-57.2%
24 Q2	-388.66%
23 Q4	-70.33%
23 Q2	-198.13%
22 Q4	-27.9%
22 Q2	-35.11%

Shares Outstanding

DXB.AX Shares Outstanding by quarter
Period	Shares Outstanding
26 Q4	600.4M
26 Q2	600.26M
25 Q4	566.09M
25 Q2	554.76M
24 Q4	500.1M
24 Q2	405.74M
23 Q4	336.72M
23 Q2	326.57M
22 Q4	326.57M
22 Q2	272.8M

Dividends (AUD)

DXB.AX Dividends (AUD) by quarter
Period	Dividends (AUD)
Sep 99	1.22
Sep 98	6.8

Book Value Per Share (AUD)

DXB.AX Book Value Per Share (AUD) by quarter
Period	Book Value Per Share (AUD)
26 Q4	-0.02
26 Q2	-0
25 Q4	0.02
25 Q2	0.01
24 Q4	0.04
24 Q2	0
23 Q4	0.02
23 Q2	0.01
22 Q4	0.04
22 Q2	0.07

Total Assets (AUD)

DXB.AX Total Assets (AUD) by quarter
Period	Total Assets (AUD)
26 Q4	58.59M
26 Q2	64.56M
25 Q4	91.18M
25 Q2	21.91M
24 Q4	32.08M
24 Q2	15.09M
23 Q4	17.76M
23 Q2	6.35M
22 Q4	16.5M
22 Q2	20.54M

Free Cash Flow Yield

DXB.AX Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-5.23%
Sep 26	-4.91%
Sep 26	-4.31%
Aug 26	-4.47%
Aug 26	-3.96%
Aug 26	-4.16%
Aug 26	-4.47%
Jul 26	-5.01%
Jul 26	-4.91%
Jul 26	-5.12%
Jul 26	-5.12%
Jul 26	-5.12%
Jun 26	-6.47%
Jun 26	-5.46%
Jun 26	-7.44%
Jun 26	-7.02%
May 26	-6.64%
May 26	-5.99%
May 26	-5.58%
May 26	-5.71%
May 26	-5.71%
Apr 26	-3.23%
Apr 26	-3.11%
Apr 26	-3.61%
Apr 26	-3.84%
Mar 26	19.17%
Mar 26	17.67%
Mar 26	16.16%
Mar 26	13.96%
Feb 26	11.91%
Feb 26	11.91%
Feb 26	11.91%
Feb 26	11.54%
Jan 26	11.2%
Jan 26	10.87%
Jan 26	10.57%
Jan 26	10.47%
Jan 26	10.28%
Dec 25	10.57%
Dec 25	10.1%
Dec 25	9.42%
Dec 25	10.1%
Nov 25	10.77%
Nov 25	12.43%
Nov 25	11.78%
Nov 25	11.78%
Oct 25	11.09%
Oct 25	10.98%
Oct 25	10.98%
Oct 25	10.28%
Oct 25	10.19%
Sep 25	-6.4%
Sep 25	-6.34%
Sep 25	-6.34%
Sep 25	-7.02%
Aug 25	-7.25%
Aug 25	-7.17%
Aug 25	-6.94%
Aug 25	-6.27%
Aug 25	-6.8%
Jul 25	-5.78%
Jul 25	-5.99%
Jul 25	-6.16%
Jul 25	-5.63%
Jun 25	-5.72%
Jun 25	-5.78%
Jun 25	-6.22%
Jun 25	-5.83%
May 25	-5.67%
May 25	-5.35%
May 25	-5.48%
May 25	-4.94%
May 25	-4.32%
Apr 25	-7.17%
Apr 25	-7.68%
Apr 25	-8.26%
Apr 25	-7.77%
Mar 25	-9.19%
Mar 25	-8.32%
Mar 25	-8.59%
Mar 25	-9.52%
Feb 25	-9.08%
Feb 25	-8.23%
Feb 25	-8.23%
Feb 25	-8.59%
Jan 25	-8.78%
Jan 25	-8.88%
Jan 25	-7.38%
Jan 25	-7.82%
Jan 25	-10.97%
Dec 24	-11.97%
Dec 24	-12.54%
Dec 24	-11.29%
Dec 24	-11.13%
Nov 24	-11.29%
Nov 24	-11.45%
Nov 24	-10.53%
Nov 24	-9.75%
Nov 24	-10.13%
Oct 24	-9.4%

Price to Sales

DXB.AX Price to Sales by quarter
Period	Price to Sales
Sep 26	17.3
Sep 26	18.4
Sep 26	20.98
Aug 26	20.24
Aug 26	22.82
Aug 26	21.72
Aug 26	20.24
Jul 26	18.04
Jul 26	18.4
Jul 26	17.67
Jul 26	17.67
Jul 26	17.67
Jun 26	13.99
Jun 26	16.56
Jun 26	12.15
Jun 26	12.88
May 26	13.62
May 26	15.09
May 26	16.2
May 26	15.83
May 26	15.83
Apr 26	27.97
Apr 26	29.08
Apr 26	25.03
Apr 26	23.56
Mar 26	27.06
Mar 26	29.36
Mar 26	32.11
Mar 26	37.16
Feb 26	43.58
Feb 26	43.58
Feb 26	43.58
Feb 26	44.95
Jan 26	46.33
Jan 26	47.71
Jan 26	49.08
Jan 26	49.54
Jan 26	50.46
Dec 25	49.08
Dec 25	51.38
Dec 25	55.05
Dec 25	51.38
Nov 25	48.17
Nov 25	41.74
Nov 25	44.04
Nov 25	44.04
Oct 25	46.79
Oct 25	47.25
Oct 25	47.25
Oct 25	50.46
Oct 25	50.92
Sep 25	28.71
Sep 25	28.99
Sep 25	28.99
Sep 25	26.18
Aug 25	25.33
Aug 25	25.61
Aug 25	26.46
Aug 25	29.27
Aug 25	27.02
Jul 25	31.81
Jul 25	30.68
Jul 25	29.84
Jul 25	32.65
Jun 25	32.09
Jun 25	31.81
Jun 25	29.55
Jun 25	31.52
May 25	32.37
May 25	34.34
May 25	33.49
May 25	37.15
May 25	42.5
Apr 25	25.61
Apr 25	23.92
Apr 25	22.24
Apr 25	23.64
Mar 25	22.48
Mar 25	24.83
Mar 25	24.04
Mar 25	21.69
Feb 25	22.74
Feb 25	25.09
Feb 25	25.09
Feb 25	24.04
Jan 25	23.52
Jan 25	23.26
Jan 25	27.96
Jan 25	26.4
Jan 25	18.82
Dec 24	17.25
Dec 24	16.47
Dec 24	18.29
Dec 24	18.56
Nov 24	18.29
Nov 24	18.03
Nov 24	19.6
Nov 24	21.17
Nov 24	20.39
Oct 24	21.95

Price/Operating Cashflow

DXB.AX Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Mar 26	5.25
Mar 26	5.7
Mar 26	6.23
Mar 26	7.21
Feb 26	8.45
Feb 26	8.45
Feb 26	8.45
Feb 26	8.72
Jan 26	8.99
Jan 26	9.26
Jan 26	9.52
Jan 26	9.61
Jan 26	9.79
Dec 25	9.52
Dec 25	9.97
Dec 25	10.68
Dec 25	9.97
Nov 25	9.34
Nov 25	8.1
Nov 25	8.54
Nov 25	8.54
Oct 25	9.08
Oct 25	9.17
Oct 25	9.17
Oct 25	9.79
Oct 25	9.88

Price to Book

DXB.AX Price to Book by quarter
Period	Price to Book
Mar 26	12.48
Mar 26	13.54
Mar 26	14.81
Mar 26	17.14
Feb 26	20.1
Feb 26	20.1
Feb 26	20.1
Feb 26	20.73
Jan 26	21.37
Jan 26	22
Jan 26	22.64
Jan 26	22.85
Jan 26	23.27
Dec 25	22.64
Dec 25	23.69
Dec 25	25.39
Dec 25	23.69
Nov 25	22.21
Nov 25	19.25
Nov 25	20.31
Nov 25	20.31
Oct 25	21.58
Oct 25	21.79
Oct 25	21.79
Oct 25	23.27
Oct 25	23.48
Sep 25	39.47
Sep 25	39.86
Sep 25	39.86
Sep 25	35.99
Aug 25	34.83
Aug 25	35.21
Aug 25	36.37
Aug 25	40.24
Aug 25	37.15
Jul 25	43.73
Jul 25	42.18
Jul 25	41.02
Jul 25	44.89
Jun 25	44.11
Jun 25	43.73
Jun 25	40.63
Jun 25	43.34
May 25	44.5
May 25	47.21
May 25	46.05
May 25	51.08
May 25	58.43
Apr 25	35.21
Apr 25	32.89
Apr 25	30.57
Apr 25	32.5
Mar 25	11.82
Mar 25	13.06
Mar 25	12.65
Mar 25	11.41
Feb 25	11.96
Feb 25	13.2
Feb 25	13.2
Feb 25	12.65
Jan 25	12.37
Jan 25	12.24
Jan 25	14.71
Jan 25	13.89
Jan 25	9.9
Dec 24	9.07
Dec 24	8.66
Dec 24	9.62
Dec 24	9.76
Nov 24	9.62
Nov 24	9.49
Nov 24	10.31
Nov 24	11.14
Nov 24	10.72
Oct 24	11.55
Oct 24	12.37
Oct 24	12.24
Oct 24	10.45
Sep 24	90.98
Sep 24	85.08
Sep 24	98.07
Sep 24	94.53
Aug 24	106.34
Aug 24	102.8
Aug 24	107.53
Aug 24	100.44
Aug 24	99.25
Jul 24	109.89
Jul 24	132.34
Jul 24	115.8
Jul 24	107.53
Jun 24	120.52
Jun 24	129.98
Jun 24	152.43
Jun 24	135.88
May 24	116.98
May 24	80.35
May 24	88.62
May 24	77.99
May 24	85.08

No video analysis for this stock yet. Request one from our team.

News: DXB.AX

proactiveinvestors.com · 16 Jun 2026

Dimerix licenses DMX-200 rights in Asia to Everest Medicines in deal worth up to A$481 million

Dimerix Ltd (ASX:DXB, OTC:SBMJF) has entered into an exclusive licence agreement with Everest Medicines for the commercialisation of its Phase 3 drug...

AI Analysis

Dimerix Limited

Video analysis: DXB.AX

News: DXB.AX

Dimerix licenses DMX-200 rights in Asia to Everest Medicines in deal worth up to A$481 million

Similar companies